184 related articles for article (PubMed ID: 19124510)
1. Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.
Birmann BM; Tamimi RM; Giovannucci E; Rosner B; Hunter DJ; Kraft P; Mitsiades C; Anderson KC; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):282-8. PubMed ID: 19124510
[TBL] [Abstract][Full Text] [Related]
2. Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival.
Nielsen KR; Rodrigo-Domingo M; Steffensen R; Baech J; Bergkvist KS; Oosterhof L; Schmitz A; Bødker JS; Johansen P; Vogel U; Vangsted A; Dybkær K; Bøgsted M; Johnsen HE
Leuk Lymphoma; 2017 Nov; 58(11):2695-2704. PubMed ID: 28393658
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.
Cozen W; Gebregziabher M; Conti DV; Van Den Berg DJ; Coetzee GA; Wang SS; Rothman N; Bernstein L; Hartge P; Morhbacher A; Coetzee SG; Salam MT; Wang W; Zadnick J; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2285-91. PubMed ID: 17119059
[TBL] [Abstract][Full Text] [Related]
4. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
[TBL] [Abstract][Full Text] [Related]
5. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis.
Shi Q; Wang XS; Li G; Shah ND; Orlowski RZ; Williams LA; Mendoza TR; Cleeland CS
Cancer; 2015 Apr; 121(7):1138-46. PubMed ID: 25469832
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation and human longevity.
Soerensen M
Dan Med J; 2012 May; 59(5):B4454. PubMed ID: 22549493
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
[TBL] [Abstract][Full Text] [Related]
9. Is there an association between variants in candidate insulin pathway genes IGF-I, IGFBP-3, INSR, and IRS2 and risk of colorectal cancer in the Iranian population?
Karimi K; Mahmoudi T; Karimi N; Dolatmoradi H; Arkani M; Farahani H; Vahedi M; Parsimehr E; Dabiri R; Nobakht H; Asadi A; Zali MR
Asian Pac J Cancer Prev; 2013; 14(9):5011-6. PubMed ID: 24175768
[TBL] [Abstract][Full Text] [Related]
10. Common genetic variation in the IGF1 associates with maximal force output.
Huuskonen A; Lappalainen J; Oksala N; Santtila M; Häkkinen K; Kyröläinen H; Atalay M
Med Sci Sports Exerc; 2011 Dec; 43(12):2368-74. PubMed ID: 21552154
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density.
Taverne CW; Verheus M; McKay JD; Kaaks R; Canzian F; Grobbee DE; Peeters PH; van Gils CH
Breast Cancer Res Treat; 2010 Oct; 123(3):843-55. PubMed ID: 20155489
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
Jung SY; Rohan T; Strickler H; Bea J; Zhang ZF; Ho G; Crandall C
PLoS One; 2017; 12(10):e0186296. PubMed ID: 29023587
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II.
Feigelson HS; Teras LR; Diver WR; Tang W; Patel AV; Stevens VL; Calle EE; Thun MJ; Bouzyk M
Breast Cancer Res; 2008; 10(4):R57. PubMed ID: 18611262
[TBL] [Abstract][Full Text] [Related]
15. Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.
Birmann BM; Neuhouser ML; Rosner B; Albanes D; Buring JE; Giles GG; Lan Q; Lee IM; Purdue MP; Rothman N; Severi G; Yuan JM; Anderson KC; Pollak M; Rifai N; Hartge P; Landgren O; Lessin L; Virtamo J; Wallace RB; Manson JE; Colditz GA
Blood; 2012 Dec; 120(25):4929-37. PubMed ID: 23074271
[TBL] [Abstract][Full Text] [Related]
16. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese.
Wong HL; Delellis K; Probst-Hensch N; Koh WP; Van Den Berg D; Lee HP; Yu MC; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):144-51. PubMed ID: 15668488
[TBL] [Abstract][Full Text] [Related]
17. Association between genetic variations in the insulin/insulin-like growth factor (Igf-1) signaling pathway and longevity: a systematic review and meta-analysis.
Di Bona D; Accardi G; Virruso C; Candore G; Caruso C
Curr Vasc Pharmacol; 2014; 12(5):674-81. PubMed ID: 24350933
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.
Dong X; Javle M; Hess KR; Shroff R; Abbruzzese JL; Li D
Gastroenterology; 2010 Aug; 139(2):464-73, 473.e1-3. PubMed ID: 20416304
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway.
Ferlin M; Noraz N; Hertogh C; Brochier J; Taylor N; Klein B
Br J Haematol; 2000 Nov; 111(2):626-34. PubMed ID: 11122111
[TBL] [Abstract][Full Text] [Related]
20. Association of IL-6 Promoter and Receptor Polymorphisms with Multiple Myeloma Risk: A Systematic Review and Meta-Analysis.
Li Y; Du Z; Wang X; Wang G; Li W
Genet Test Mol Biomarkers; 2016 Oct; 20(10):587-596. PubMed ID: 27525545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
